Medtep Competitors and Similar CompaniesClear all
NIOX's competitors and similar companies include Affimed N.V. and BTG.
 NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies |  Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 1948 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Heidelberg, DE HQ | |
Employees | Employees 91 | Employees 76 | Employees 650 |
Valuation ($) | Valuation ($) 340.9 m | Valuation ($) 52.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods £11.1m (FY, 2025) | Cost of goods N/A | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit £38.2m (FY, 2025) | Gross profit €13m (FY, 2023) | Gross profit £510.3m (FY, 2019) |
Net income | Net income £7m (FY, 2025) | Net income (€105.9m) (FY, 2023) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Affimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company